Medical Xpress news
Medical Xpress / Inhibiting protein to treat myeloproliferative neoplasms shows preclinical promise
Inhibiting menin, a protein that supports leukemia growth and is already targeted to treat some forms of leukemia, also holds promise for treating myeloproliferative neoplasms. A new study from scientists at St. Jude Children's ...
Medical Xpress / Demystifying the molecular mechanisms of general anesthesia
Researchers at Weill Cornell Medicine and Birkbeck, University of London, have identified a site where a commonly used anesthetic binds to sodium ion channels, revealing a molecular mechanism that may explain how these drugs ...
Medical Xpress / Second prostate-specific membrane antigen PET scan can change treatment for nearly half of prostate cancer patients
A second prostate-specific membrane antigen (PSMA) PET scan changed treatment plans for nearly half of patients whose first scan was negative, according to new research published in the July issue of The Journal of Nuclear ...
Medical Xpress / The same sounds are mapped similarly in the human and mouse brain, study finds
While exploring the world around them, both humans and other animals continuously interpret information they pick up with their sight, hearing, touch and other senses. Neuroscience research suggests that the brain does not ...
Medical Xpress / Engineers develop AI tool to design peptides that turn signals on or off
To develop new and better peptides, the short amino acid strings behind medicines like GLP-1 drugs, researchers have used AI to generate candidates and to predict their properties.
Medical Xpress / Artemisinin resistance is rising in East Africa—leaving anti-malarials at risk of failure
Resistance to the main drug in front-line malaria treatments is becoming more widespread across East Africa, according to new research by Imperial College London. The study, published in The Lancet Infectious Diseases, maps ...
Medical Xpress / Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial
Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational once-weekly injection for diabetes management, can significantly improve blood sugar levels and lead to ...
Medical Xpress / How studying oral inflammatory diseases can help researchers understand other human diseases
A team of researchers from VCU Massey Comprehensive Cancer Center, the VCU School of Dentistry and the University of Pennsylvania recently published a study in Nature Communications examining why some oral inflammatory diseases ...
Medical Xpress / Bacterial responses to plasma may forecast mild vs severe COVID-19
Information processing using living organisms is an important area of biotechnology that has already been explored in previous studies.
Medical Xpress / Brain glutamate changes could link cannabis use to a higher risk of psychosis
Cannabis, commonly known as marijuana, is a plant that contains psychoactive compounds that can temporarily alter people's brain activity and perceptions. While the consumption of this plant for medical or recreational purposes ...
Medical Xpress / New study provides first evidence of dopamine system injury in the brain of long COVID patients
A new brain imaging study led by researchers at the Center for Addiction and Mental Health (CAMH), published in eBioMedicine, provides the strongest evidence to date that long COVID is associated with injury to dopamine-releasing ...
Medical Xpress / Fasting primes gut microbiome to improve intestinal recovery after radiation treatment
A new preclinical study from the University of Texas MD Anderson Cancer Center has identified a gut bacterium that, when combined with short-term fasting, helps prepare the small intestine to regenerate more effectively after ...
